These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29909653)

  • 21. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia.
    Ohsawa M; Tamura K; Wakui H; Kanaoka T; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Toya Y; Umemura S
    Lipids Health Dis; 2015 Dec; 14():161. PubMed ID: 26645467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
    Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
    J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells.
    Deakin S; Moren X; James RW
    Atherosclerosis; 2005 Mar; 179(1):17-25. PubMed ID: 15721005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
    Pawlak K; Mysliwiec M; Pawlak D
    Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome.
    Zhang J; Zhang Y; Liu H; Bai H; Wang Y; Jiang C; Fan P
    Fertil Steril; 2015 May; 103(5):1346-54. PubMed ID: 25813288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.
    Samouilidou E; Bountou E; Papandroulaki F; Papamanolis M; Papakostas D; Grapsa E
    Ther Apher Dial; 2018 Aug; 22(4):325-331. PubMed ID: 29368426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein-treated endothelial progenitor cells: a novel index for the prediction of HDL functionality.
    Shih CM; Lin FY; Yeh JS; Lin YW; Loh SH; Tsao NW; Nakagami H; Morishita R; Sawamura T; Li CY; Lin CY; Huang CY
    Transl Res; 2019 Mar; 205():17-32. PubMed ID: 30720435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome.
    Lőrincz H; Harangi M; Oláh AV; Szabó GP; Fülöp P; Somodi S; Paragh G; Seres I
    Pediatr Res; 2015 May; 77(5):703-9. PubMed ID: 25668223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
    Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma lipid level and incidence of dyslipidemia in workers of Chongqing enterprises and institutions].
    Gao Y; Zhong XN; Yang YH; Tian KC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):432-5. PubMed ID: 22883098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia.
    Agouridis AP; Tsimihodimos V; Filippatos TD; Dimitriou AA; Tellis CC; Elisaf MS; Mikhailidis DP; Tselepis AD
    Expert Opin Pharmacother; 2011 Dec; 12(17):2605-11. PubMed ID: 21714585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.
    Charles-Schoeman C; Meriwether D; Lee YY; Shahbazian A; Reddy ST
    Clin Rheumatol; 2018 Mar; 37(3):615-622. PubMed ID: 29129008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
    He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
    Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.
    Ansari MR; Maheshwari N; Shaikh MA; Laghari MS; ; Lal K; Ahmed K
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):21-5. PubMed ID: 22237213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
    Quispe R; Al-Hijji M; Swiger KJ; Martin SS; Elshazly MB; Blaha MJ; Joshi PH; Blumenthal RS; Sniderman AD; Toth PP; Jones SR
    J Clin Lipidol; 2015; 9(4):511-8.e1-5. PubMed ID: 26228668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia.
    Perovic Blagojevic IM; Vekic JZ; Macut DP; Ignjatovic SD; Miljkovic-Trailovic MM; Zeljkovic AR; Spasojevic-Kalimanovska VV; Bozic-Antic IB; Bjekic-Macut JD; Kastratovic-Kotlica BA; Andric ZG; Ilic DS; Kotur-Stevuljevic JM
    Br J Nutr; 2022 Aug; 128(4):604-612. PubMed ID: 34511137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.